BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26458014)

  • 1. Glucocorticoids and the osteoclast.
    Teitelbaum SL
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S37-9. PubMed ID: 26458014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of glucocorticoid-induced osteoporosis: lessons for clinical practice.
    Roux C; Rajzbaum G; Morel G; Legrand E; Laroche M; Hoppé E; Chopin F; Borg S; Biver E; Cortet B; Thomas T
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S222-6. PubMed ID: 22153676
    [No Abstract]   [Full Text] [Related]  

  • 4. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.
    Weinstein RS; Chen JR; Powers CC; Stewart SA; Landes RD; Bellido T; Jilka RL; Parfitt AM; Manolagas SC
    J Clin Invest; 2002 Apr; 109(8):1041-8. PubMed ID: 11956241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients.
    Jobke B; Milovanovic P; Amling M; Busse B
    Bone; 2014 Feb; 59():37-43. PubMed ID: 24211427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting the optimal treatment for glucocorticoid-induced osteoporosis.
    Chopin F; Hoppé E; Morel G; Biver E; Borg S; Thomas T
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S218-21. PubMed ID: 22153675
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of glucocorticoid-induced osteoporosis.
    Canalis E
    Curr Opin Rheumatol; 2003 Jul; 15(4):454-7. PubMed ID: 12819474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucocorticoid-induced osteoporosis : treatment update].
    Soen S
    Clin Calcium; 2012 Feb; 22(2):229-35. PubMed ID: 22298077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies on glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Aug; 24(4):142-151. PubMed ID: 16646164
    [No Abstract]   [Full Text] [Related]  

  • 10. Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway.
    Li F; Sun X; Ma J; Ma X; Zhao B; Zhang Y; Tian P; Li Y; Han Z
    Biochem Biophys Res Commun; 2014 Sep; 452(3):629-35. PubMed ID: 25181344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Resorptive Functions of Poly(ethylene sodium phosphate) on Human Osteoclasts.
    Kootala S; Tokunaga M; Hilborn J; Iwasaki Y
    Macromol Biosci; 2015 Dec; 15(12):1634-40. PubMed ID: 26222677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis].
    Tanaka I
    Clin Calcium; 2014 Sep; 24(9):1371-8. PubMed ID: 25177010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation.
    Wang XF; Wang YJ; Li TY; Guo JX; Lv F; Li CL; Ge XT
    Biomed Pharmacother; 2019 Jul; 115():108916. PubMed ID: 31054506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of glucocorticoid-induced osteoporosis.
    van Brussel MS; Bultink IE; Lems WF
    Expert Opin Pharmacother; 2009 Apr; 10(6):997-1005. PubMed ID: 19351276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
    Li M; Saito T; Amizuka N
    Clin Calcium; 2008 Mar; 18(3):328-35. PubMed ID: 18310820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of glucocorticoid action in bone.
    Canalis E; Delany AM
    Ann N Y Acad Sci; 2002 Jun; 966():73-81. PubMed ID: 12114261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological topics of bone metabolism: antiresorptive microbial compounds that inhibit osteoclast differentiation, function, and survival.
    Woo JT; Yonezawa T; Cha BY; Teruya T; Nagai K
    J Pharmacol Sci; 2008 Apr; 106(4):547-54. PubMed ID: 18431038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piper sarmentosum prevents glucocorticoid-induced osteoporotic bone resorption by increasing 11β-hydroxysteroid dehydrogenase type 1 activity.
    Suhana MR; Farihah HS; Faizah O; Nazrun SA; Norazlina M; Norliza M; Nirwana SI
    Clin Ter; 2011; 162(4):313-8. PubMed ID: 21912818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoid-induced osteoporosis].
    Foltyn W; Kos-Kudła B; Marek B; Kajdaniuk D; Głogowska-Szelag J; Siemińska L; Strzelczyk J; Borowska M
    Endokrynol Pol; 2007; 58(2):170-5. PubMed ID: 17578833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.